Activa is an anti-infective and acute/critical-care therapy franchise. It is based on a strong injectables platform complemented by the company's sterile-injectables capabilities.
Provide stable acute-care, injectables for hospital administration, and rapid-response products that are clinically effective, accessible, and scalable in Synokem's WHO-GMP production facility and Nitin Lifesciences' facilities.
What Activa Stands For
High-Volume Acute Therapies
Oral Solid and Injectable Range
Quality & Trust
Key Focus Areas
Anti-Infectives (Acute)
Antibiotics, antifungals employed in the management of hospital and community high-burden infections. Critical-Care
Injectables
Parenteral medications specifically designed for ICU/ER patients and rapid, focused delivery.
Respiratory, Acute & Exacerbations
Solutions for asthma/COPD exacerbation treatment.
Preventative & Recovery Adjuncts
Probiotics, nutraceuticals, vitamins/minerals supplementing acute regimes and recovery.
Why Activa (Backed by the Group)
Strengthened by the legacy and WHO-GMP manufacturing excellence of Synokem Pharmaceuticals Ltd. at Haridwar. Supported by the advanced infrastructure of Nitin Lifesciences Ltd. across Himachal Pradesh and Haryana. Built on stringent sterility protocols and uncompromised quality benchmarks. Ensuring batch-to-batch consistency, scalable capacity, and complete clinical confidence.